Substance Abuse Treatment by Abuse Type, Treatment Type | End User, Region

Market Highlights
The Global substance abuse treatment market is expected to grow at an approximate CAGR of 11.6% during forecast period, 2018–2023.

Increasing cases of tobacco smoking are one of the prominent factors driving the substance abuse treatment market. According to the information published in the Frontiers in Psychiatry journal, China is facing an immense public health challenge from tobacco smoking. It is estimated that a number of deaths, due to cigarette smoking, will reach 2 million by 2030 and 3 million by 2050.
Various other factors such as increased incidence of drug addiction, technological advancement in the diagnostics industry, rising patient awareness about substance abuse treatment and improvement in treatment rates and healthcare infrastructure are also expected to propel the growth of the market.


Key Players
Some of the key players in the global substance abuse treatment market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., Purdue Pharma LP, Allergan, Mylan Laboratories, Reckitt Benckiser Pharmaceuticals, Teva Pharmaceuticals, Forest Laboratories, Inc., Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharmaceuticals, and others.

Segmentation
The Global substance abuse treatment market is segmented based on abuse type, treatment type, end user, and region.

The Global market for substance abuse treatment, by abuse type, is segmented into alcohol dependence, tobacco/nicotine addiction, and drug abuse. The drug abuse segment is anticipated to hold the largest market share owing to the increasing addiction of opioid.

The market, by treatment type, is segmented into alcohol addiction treatment, tobacco/nicotine addiction treatment, and drug abuse treatment. The alcohol addiction treatment segment is further classified as disulfiram, acamprosate, and naltrexone. The tobacco/nicotine addiction treatment segment is further classified as nicotine replacement treatment and non-nicotine medication. The nicotine replacement treatment segment includes the nicotine patch, nicotine gum, nicotine lozenge, nicotine spray, and nicotine inhaler. The non-nicotine medication segment includes bupropion and varenicline. The drug abuse treatment segment is further classified as methadone, buprenorphine, and naltrexone.

Based on the end user, the market is segmented into outpatient treatment centers, residential treatment centers, and inpatient treatment centers.


Regional Analysis
The Americas dominated the global market for substance abuse treatment owing to the presence of major market players and raising awareness about substance abuse treatment within the region. In recent years, various private and government organizations have launched campaigns and seminar to spread awareness about substance abuse. For instance, in February 2017, the Ad Council and Viacom have launched the LISTEN campaign and a new PSA to address America’s substance abuse crisis.
In 2017, it was estimated that Europe stood second in the global substance abuse treatment market. This can be attributed to rising research and development investments.


Comments

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Surgical Drapes and Gowns Market is Growing Dynamically at a Speedy CAGR of 4.4% During Forecast 2018-2023

Dental Lasers Market Growth Values, Advanced Share, Demand Overview and Industry Forecast to 2023